Citrus Sinensis ID: 000581


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060------1070------1080------1090------1100------1110------1120------1130------1140------1150------1160------1170------1180------1190------1200------1210------1220------1230------1240------1250------1260------1270------1280------1290------1300------1310------1320------1330------1340------1350------1360------1370------1380------1390------1400------141
MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKAWKAQKMNTKGTRMLNVH
ccccccccccHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccHHccccccccHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHccHHHHHHHHccHHHHHHHHHHHHccccccHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHccccHHHHHHHHHHHccHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHccccccccccccccHHHHHHccccccccccccccccccHHHHHHHHHHHcHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHccHHHHHHHHHHHHHccHHHHcccccccccccccccccccccccHHHHHHcccHHHHHHHHHHcccHHHHHHHHHccccccccccccHHHHHHHHHHHHHcccccccccHHccccccccccccccHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHccccccccHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccHHHHHHHHHHHHHHccccccHHHHHHHHHHcHHHHHcccHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHccccHHHHHHHHHHHHHHccccccHHcHHHHHHHHccccccccccHHHHHHHHHHHHHHHHccHHHHHHHHHHHHccccHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHcccccccccccccccccccccccccEEEEEccEEEEcccccccEEEEEEEccccEEEEEcccccccccHHHHHHHHHHHHHHHHccccccccccccEEEEcEEEcccccEEEEEcccccHHHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHHHHHHccHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEEEEccHHHcccccccccccccccccHHHHHHccccccccHHHHHHHHHHHHHHccHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHccccccccccc
ccHHHcccccHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccccccEEEEEEccccEEEccccHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHcccccHHHHHHccHHcHHHHccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHccccccccHHHHHHHHHHHHccHHHHHHHHHHHcccccHHHHHHHcccccccccccccccHHHHHccccccccccEccHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHccccccHHHHHcHHcHHHHHHHHHHHccHHHHHHHHHHHHHcccccHHHHHccccHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHcccccccccccHHHHHHHHHHHHHHcccHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHcHcccHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHccHHcccHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHccccHHHHcHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccHHHHHHHHHHccccccHHHHHHHHHHHHHHHcccccHHccHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHccHccHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccEEEcccHHccHccccccEEccccccccccccccccccEEEEEEcccEEEEEccccccEEEEEEEccccEEEEEEcccccHHHHHHHHHHHHHHHHHHHHccHHHHHcccEEEEEEEEEccccccEEEEccccccHHHHHHHHHHHccccccccccHHHHHHHHHHccHHHHHHHHHHHHHHccccHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHEcccccccccEEEEccccEEEEEEcHHHHHHHcccccccccccEccHHHHHHccccccccHHHHHHHHHHHHHHHcHHHHHHHHHHHHccccHHccccHHHHHHHcccccccccccccEEEEEcc
meevvdwhsdhdIVHAVWTLVHMCCSDDASSIRAWVSDFISrvgigdphcvvfhlprdsiymhacrpinhgsgsatefnfhldaGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFkangispekstvwetdgktfetwicpltysligcCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVmersssvppkresskyvkhsgssakprstsakarDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYksltlgspdfshletlPRHIEILVSAVtqinepdslyGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMlqmdgnsgalsphglpsvhlspstsenemmqrkpykgLMRSLQQVGCMHVLDMYCKGltswkgqfqhdpeftKLQYEAAWRtgnwdfslpylganfpsgqniksghfhENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGvawdirwkssgesiniypekqkivsepviptvgqlswlNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKflytgpgdqcstvyWLGRLEEAKLLRAQGQHEMAINLAKYISenyesneeapDVYRLVGKWLAesrssnsriilenylkpavsfsedqrttdkkSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKsstkgektdYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIdevqsykfIPLVYQIASRMgstkdalgLHNFQFALVSLVKKMAIDHPYHTIFQLLALAngdrikdkqrsrnsfvvDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLrqlelvpvvtatvpidctcqynegsfpyfKGLAESVMVMnginapkvvecfgsdghkyRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDtwkrrlgvrtykvvpftpsagilewvdgtvplgdyligstrnggahgrygigdwsfLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAfeqglmlktpervpfrltrdiidgmgvtgvEGVFRRCCEKTLSVMRTNKEALLTIVEVFIhdplykwalsPLKALQRQKAWKAQKMntkgtrmlnvh
MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERkfkangispekstvwetdgKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMersssvppkresskyvkhsgssakprstsakardvvatsnatmttswdkVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYpekqkivsepviPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAEsrssnsriilenylkpavsfsedqRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKrlksstkgektdysiKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAeletrredtnkriqlpreirclrqlelVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFlrnhrdtwkrrlgvrtykvvpftpsagilewVDGTVPLGDYLIGstrnggahgrYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFeqglmlktpervpfRLTRDIIDgmgvtgvegVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKAWKAqkmntkgtrmlnvh
MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKlaaenlleelSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKAWKAQKMNTKGTRMLNVH
***VVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVM***************************************NATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVML************************************LMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESR**NSRIILENYLKPAV***************RQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKR********************************LLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRI********SFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAK***DDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQR********************
******WHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHA********GSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLL**********ISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESN****SIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSG******************SNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCE******************LPRHIEILVSAVTQINEPDSLYGIIQSHKLSS*IVTLEHEGNWSKALEYYELQVRSDVMLQ****SGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGA*******IKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWK***********KQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHEL*************VYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAE********ILENYLKPAVSFSED******KSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALAN********************KLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETR*************IRCLRQLE******************EGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGA**RYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKW******************************
********SDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVME*************************************SNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVS*************ERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLK********DYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKAL**********************
MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPP************************R**V*TSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYK***********LETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQ***SGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKS*************IVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQR***WKAQKMNTKGTR*L***
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGExxxxxxxxxxxxxxxxxxxxxxxxxxxxRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKAWKAQKMNTKGTRMLNVH
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query1408 2.2.26 [Sep-21-2011]
Q9M3G73856 Serine/threonine-protein yes no 0.975 0.356 0.690 0.0
Q623883066 Serine-protein kinase ATM yes no 0.849 0.390 0.326 1e-179
Q6PQD53057 Serine-protein kinase ATM yes no 0.839 0.386 0.324 1e-177
Q133153056 Serine-protein kinase ATM yes no 0.843 0.388 0.323 1e-177
Q4WVM72796 Serine/threonine-protein yes no 0.452 0.227 0.358 1e-114
Q4IB892813 Serine/threonine-protein yes no 0.681 0.340 0.293 1e-114
Q7RZT92939 Serine/threonine-protein N/A no 0.452 0.216 0.339 1e-106
Q2U6392925 Serine/threonine-protein yes no 0.424 0.204 0.359 1e-106
Q5BHE22793 Serine/threonine-protein yes no 0.452 0.228 0.343 1e-105
O746302812 Serine/threonine-protein yes no 0.421 0.211 0.339 1e-104
>sp|Q9M3G7|ATM_ARATH Serine/threonine-protein kinase ATM OS=Arabidopsis thaliana GN=ATM PE=2 SV=1 Back     alignment and function desciption
 Score = 1984 bits (5141), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 961/1391 (69%), Positives = 1149/1391 (82%), Gaps = 18/1391 (1%)

Query: 7    WHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACR 66
            W SD +IV+AVWTLV +  SD+A S+R  VSDF+SR+GI DPH VVFHLP + + MH  +
Sbjct: 2404 WQSDDEIVNAVWTLVRVSASDEADSMRLLVSDFLSRIGIRDPHTVVFHLPGNLVSMHGLQ 2463

Query: 67   PINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKG 126
               H +GS  +     + GIS+E LI +L  LKKYL+DDSV+I+D+TSQTLRGILSTE+G
Sbjct: 2464 GFGHNTGS--KVRSLTENGISDETLITLLNFLKKYLLDDSVKIIDVTSQTLRGILSTERG 2521

Query: 127  QRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFET 186
            Q+A+ SFDS ER+L+EVH +GVN+++VE  LLD +++FKA   S E   VW TD K F+ 
Sbjct: 2522 QQALSSFDSCERALIEVHGRGVNLDIVEKILLDSQKQFKAEKFSLETPEVWSTDNKNFDR 2581

Query: 187  WICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQ 246
            WIC L Y +I  C DV +RLCQ+I LLK+E++ELL PSVVV+LAG   +D++L  LI+SQ
Sbjct: 2582 WICQLVYCMIALCEDVPIRLCQNIALLKAEISELLFPSVVVSLAGRIGMDINLHDLITSQ 2641

Query: 247  VQKYIFTESNKLIKSIQVFLNALNELRLCHVMERS-SSVPPKRESSKYVKHSGSSAKPRS 305
            V+++IFT+SNKL KS QV LN LNELR+C+V+ERS  S   KRE     K+S S     S
Sbjct: 2642 VKEHIFTDSNKLTKSKQVMLNTLNELRMCYVLERSIFSGQTKRE-----KNSRSC----S 2692

Query: 306  TSAKARDVVATSN---ATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEH 362
            T+AK RDV + SN   A++TT+W+KVYWLS+DYL VA SAV+CG+Y T+ MYVE+WCEE 
Sbjct: 2693 TAAKIRDVESGSNGMAASITTNWEKVYWLSIDYLVVAGSAVVCGAYLTASMYVEYWCEEK 2752

Query: 363  YKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWS 422
            + +L+LG PDFS+ + LP H+EILVSA+T+INEPDSLYG+I S+KLS+QI+T EHEGNW+
Sbjct: 2753 FGNLSLGDPDFSYHDKLPDHVEILVSAITRINEPDSLYGVIHSNKLSAQIITFEHEGNWT 2812

Query: 423  KALEYYELQVRSDVMLQMDGNSGALSPHGL-PSVHLSPSTSENEMMQRKPYKGLMRSLQQ 481
            +ALEYY+LQ RS  M+     S  L      P+     S      +QR+P+KGL+RSLQQ
Sbjct: 2813 RALEYYDLQARSQKMVVPSSLSENLEVEQFQPTTSARHSVFGEGEVQRQPFKGLIRSLQQ 2872

Query: 482  VGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKS 541
             GCMHVLD+YC+GLTS +G FQ+DPEF +LQYEAAWR G WDFSL Y   +    Q+ K+
Sbjct: 2873 TGCMHVLDLYCRGLTSREGCFQYDPEFIELQYEAAWRAGKWDFSLLYPQTHCQPLQHAKN 2932

Query: 542  GHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCH 601
             ++HE+LH CL AL+EGD + FY KLK +K+ELVLS++ ASEESTE+IYS +VKLQIL H
Sbjct: 2933 NNYHESLHCCLRALQEGDYDGFYGKLKDTKKELVLSISRASEESTEFIYSTVVKLQILHH 2992

Query: 602  LGVAWDIRWK-SSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLE 660
            LG+ WD+RW  SS +S++ Y  KQ    +PVIPT+ QLSWLN +W+SI+ +TQLHM LLE
Sbjct: 2993 LGLVWDLRWTTSSHQSVHGYLVKQMACVDPVIPTMDQLSWLNKDWNSIITQTQLHMTLLE 3052

Query: 661  PFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTV 720
            PF+AFRRVLLQIL C+  TMQHLL+SAS LRKG R S AAA+LHE KFL      Q    
Sbjct: 3053 PFIAFRRVLLQILGCEKCTMQHLLQSASLLRKGTRFSHAAASLHEFKFLCARSNGQQPVP 3112

Query: 721  YWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRII 780
             WLG+LEEAKLL AQG+HE++I+LA YI  NY+  EEA D+YR++GKWLAE+RSSNSR I
Sbjct: 3113 DWLGKLEEAKLLHAQGRHEVSISLANYILHNYQLKEEASDIYRVIGKWLAETRSSNSRTI 3172

Query: 781  LENYLKPAVSFSEDQRTTD-KKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRL 839
            LE YL+PAVS +E+Q +   K+ ++RQ QT FHLAHYADALFKSYEERL+S+EWQAA+RL
Sbjct: 3173 LEKYLRPAVSLAEEQSSKICKRLVDRQSQTWFHLAHYADALFKSYEERLSSSEWQAALRL 3232

Query: 840  RKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALE 899
            RKHKT ELE  IKR KSS K E++DYS+KIQ+LQKQL MD+EEA+KL  DRDNFL LALE
Sbjct: 3233 RKHKTKELEVFIKRFKSSKKAEQSDYSLKIQDLQKQLTMDKEEAEKLQVDRDNFLKLALE 3292

Query: 900  GYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRM 959
            GYKRCL IGDKYDVRVVFR VS+WFSL+S++NVI NM+ TI EVQSYKFIPLVYQIASR+
Sbjct: 3293 GYKRCLEIGDKYDVRVVFRQVSMWFSLASQKNVIDNMLSTIKEVQSYKFIPLVYQIASRL 3352

Query: 960  GSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDK 1019
            GS+KD  G ++FQ ALVSL++KMAIDHPYHTI QLLALANGDRIKD QRSRNSFVVDMDK
Sbjct: 3353 GSSKDESGSNSFQSALVSLIRKMAIDHPYHTILQLLALANGDRIKDNQRSRNSFVVDMDK 3412

Query: 1020 KLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLEL 1079
            KLAAE+LL+++S YHG +IRQMKQ+VD+YIKLAELETRREDTN+++ LPREIR ++QLEL
Sbjct: 3413 KLAAEHLLQDVSHYHGPMIRQMKQLVDIYIKLAELETRREDTNRKVALPREIRSVKQLEL 3472

Query: 1080 VPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSG 1139
            VPVVTAT+P+D +CQYNEGSFP+F+GL++SV VMNGINAPKVVECFGSDG KY+QLAKSG
Sbjct: 3473 VPVVTATIPVDRSCQYNEGSFPFFRGLSDSVTVMNGINAPKVVECFGSDGQKYKQLAKSG 3532

Query: 1140 NDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGD 1199
            NDDLRQDAVMEQFFGLVNTFL N+RDTWKRRL VRTYKV+PFTPSAG+LEWVDGT+PLGD
Sbjct: 3533 NDDLRQDAVMEQFFGLVNTFLHNNRDTWKRRLAVRTYKVIPFTPSAGVLEWVDGTIPLGD 3592

Query: 1200 YLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQ 1259
            YLIGS+R+ GAHGRYGIG+W + KCREHMS+ KDKR AF +VC NFRPV+HYFFLE+FLQ
Sbjct: 3593 YLIGSSRSEGAHGRYGIGNWKYPKCREHMSSAKDKRKAFVDVCTNFRPVMHYFFLEKFLQ 3652

Query: 1260 PAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLK 1319
            PA WF KRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLK
Sbjct: 3653 PADWFVKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLK 3712

Query: 1320 TPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWA 1379
            TPERVPFRLTRDIIDGMG+TGVEGVFRRCCE+TLSVMRTNKEALLTIVEVFIHDPLYKWA
Sbjct: 3713 TPERVPFRLTRDIIDGMGITGVEGVFRRCCEETLSVMRTNKEALLTIVEVFIHDPLYKWA 3772

Query: 1380 LSPLKALQRQK 1390
            LSPLKALQRQK
Sbjct: 3773 LSPLKALQRQK 3783




Serine/threonine protein kinase which activates checkpoint signaling upon genotoxic stresses such as ionizing radiation (IR) or DNA replication stalling. Plays a central role in the perception and response to both stress-induced damage in somatic cells and developmentally programmed DNA damage during meiosis. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates histone variant H2AX to form H2AXS139ph at double strand breaks (DSBs), thereby regulating DNA damage response mechanism. Involved in transcriptional regulation of RAD51, PARP1, GR1, and LIG4 in response to DNA double strand breaks. Plays a dual role by activating the DNA damage response at dysfunctional telomeres and yet preventing this activation at functional telomeres. Not required for telomere length homeostasis.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1
>sp|Q62388|ATM_MOUSE Serine-protein kinase ATM OS=Mus musculus GN=Atm PE=1 SV=2 Back     alignment and function description
>sp|Q6PQD5|ATM_PIG Serine-protein kinase ATM OS=Sus scrofa GN=ATM PE=3 SV=2 Back     alignment and function description
>sp|Q13315|ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 Back     alignment and function description
>sp|Q4WVM7|ATM_ASPFU Serine/threonine-protein kinase tel1 OS=Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) GN=tel1 PE=3 SV=2 Back     alignment and function description
>sp|Q4IB89|ATM_GIBZE Serine/threonine-protein kinase TEL1 OS=Gibberella zeae (strain PH-1 / ATCC MYA-4620 / FGSC 9075 / NRRL 31084) GN=TEL1 PE=3 SV=1 Back     alignment and function description
>sp|Q7RZT9|ATM_NEUCR Serine/threonine-protein kinase tel-1 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) GN=tel-1 PE=3 SV=2 Back     alignment and function description
>sp|Q2U639|ATM_ASPOR Serine/threonine-protein kinase tel1 OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) GN=tel1 PE=3 SV=1 Back     alignment and function description
>sp|Q5BHE2|ATM_EMENI Serine/threonine-protein kinase tel1 OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) GN=tel1 PE=3 SV=1 Back     alignment and function description
>sp|O74630|ATM_SCHPO Serine/threonine-protein kinase tel1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=tel1 PE=1 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query1408
359491245 2956 PREDICTED: serine/threonine-protein kina 0.970 0.462 0.783 0.0
297733786 3085 unnamed protein product [Vitis vinifera] 0.970 0.442 0.760 0.0
255540663 2954 ataxia telangiectasia mutated, putative 0.972 0.463 0.762 0.0
356507238 3439 PREDICTED: serine/threonine-protein kina 0.970 0.397 0.747 0.0
449441017 2985 PREDICTED: LOW QUALITY PROTEIN: serine/t 0.973 0.459 0.726 0.0
56748564 3856 RecName: Full=Serine/threonine-protein k 0.975 0.356 0.690 0.0
7529272 3856 ataxia-telangiectasia mutated protein (A 0.975 0.356 0.690 0.0
240255538 3845 serine/threonine-protein kinase [Arabido 0.967 0.354 0.684 0.0
297815998 3832 hypothetical protein ARALYDRAFT_323420 [ 0.966 0.355 0.679 0.0
222617585 2743 hypothetical protein OsJ_00056 [Oryza sa 0.948 0.486 0.607 0.0
>gi|359491245|ref|XP_002279402.2| PREDICTED: serine/threonine-protein kinase ATM [Vitis vinifera] Back     alignment and taxonomy information
 Score = 2218 bits (5747), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 1087/1388 (78%), Positives = 1208/1388 (87%), Gaps = 22/1388 (1%)

Query: 7    WHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACR 66
            W +D DIVHAVW LVHMC SDDA+S+RA VSDFISRVGIGDPHCVVFHLP D   +H CR
Sbjct: 1514 WRADQDIVHAVWNLVHMCGSDDANSVRALVSDFISRVGIGDPHCVVFHLPGDYSQIHVCR 1573

Query: 67   PINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKG 126
            PI+H SG+  E +F LD  ISEELL+A++++LKKYLMDDSV+I+D+TSQTL GILSTE+G
Sbjct: 1574 PIHHDSGA--EISFPLDTSISEELLLALMRLLKKYLMDDSVKIIDLTSQTLWGILSTERG 1631

Query: 127  QRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFET 186
            Q+A++SFDSYERSL+EVHSKGVNVELVE  L DLE+KF A  I  EKST+W+T  KTFE 
Sbjct: 1632 QKALLSFDSYERSLIEVHSKGVNVELVEKLLSDLEKKFNAEAIPLEKSTIWKTHEKTFEM 1691

Query: 187  WICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQ 246
            WICPL +SLIG CND +LRLCQDIVLLK+EVAELLLP+V+VNLAG K++ VDL KLISSQ
Sbjct: 1692 WICPLVHSLIGFCNDTILRLCQDIVLLKAEVAELLLPNVIVNLAGRKDLAVDLCKLISSQ 1751

Query: 247  VQKYIFTESNKLIKSIQVFLNALNELRLCHVMER--SSSVPPKRESSKYVKHSGSSAKPR 304
            VQ+ IF ESN+ IKSIQV L+ALNELRL +VMER  SSS+P KRE+S+    + SS    
Sbjct: 1752 VQENIFVESNRSIKSIQVMLDALNELRLFYVMERTTSSSIPLKRETSRVNSSTMSSVALV 1811

Query: 305  STSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYK 364
            STS                 W+KVYWLS+DYL VAKSA+ICGSYFTSVMYVEHWCEEH+ 
Sbjct: 1812 STSL----------------WEKVYWLSIDYLDVAKSAIICGSYFTSVMYVEHWCEEHFN 1855

Query: 365  SLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKA 424
            SLTLG PDFSH E LP HIEILVSA+TQINEPDSLYGIIQ HKL+SQI+T EHEGNWSKA
Sbjct: 1856 SLTLGKPDFSHCEMLPHHIEILVSAITQINEPDSLYGIIQLHKLTSQIITFEHEGNWSKA 1915

Query: 425  LEYYELQVRSDVMLQMDGNSGALSP-HGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVG 483
            LEYY+LQVRS+ +  MDG+S  LSP H   +VH S S SE+ + QR+PYKGL+RSLQ++G
Sbjct: 1916 LEYYDLQVRSEPVAGMDGSSRNLSPEHSQLTVHPSFSKSEDVIRQREPYKGLIRSLQKIG 1975

Query: 484  CMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSG-QNIKSG 542
            C HVLD+YC+GLTS  GQFQHD EFT+LQYEAAWR GNWDFSL Y+GAN PS  Q+I+  
Sbjct: 1976 CTHVLDLYCQGLTSQNGQFQHDLEFTELQYEAAWRAGNWDFSLLYMGANSPSSSQHIRCD 2035

Query: 543  HFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHL 602
            HF+ENLHSCL A +EGD  EF+ KLK SKQELVLSV  AS +STEYIYS I+KLQI  HL
Sbjct: 2036 HFNENLHSCLRAFQEGDFNEFHSKLKDSKQELVLSVCHASGQSTEYIYSTIIKLQIFYHL 2095

Query: 603  GVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPF 662
            G+AW +RW    E I   P  QK+ SEP+IPT+ QLSWLNT+WSSILKRTQLHMNLLEPF
Sbjct: 2096 GMAWGLRWAPPSEKIETSPGMQKVFSEPIIPTMDQLSWLNTDWSSILKRTQLHMNLLEPF 2155

Query: 663  MAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYW 722
            +AFRRVLLQILS KD  +QHLL+S+STLRKG R SQAAAALHE KFL    G+Q S  YW
Sbjct: 2156 IAFRRVLLQILSSKDCMVQHLLQSSSTLRKGSRFSQAAAALHEFKFLCNRMGEQHSASYW 2215

Query: 723  LGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILE 782
            LGRLEEAKLLRAQGQHEMAINLAKYIS+N + NEEA +VYRLVGKWLAE+RSSNSR ILE
Sbjct: 2216 LGRLEEAKLLRAQGQHEMAINLAKYISQNSQLNEEASNVYRLVGKWLAETRSSNSRTILE 2275

Query: 783  NYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKH 842
             YLK AV  ++D + TDKK+IERQ QTHFHLAHYADALF+S+EERLASNEWQAA RLRKH
Sbjct: 2276 KYLKRAVLLAKDNKNTDKKTIERQSQTHFHLAHYADALFRSHEERLASNEWQAATRLRKH 2335

Query: 843  KTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYK 902
            KTIELEALIKRL+SS+KGEKTDYS+KIQELQKQLAMD EEA+KL DDRDNFL L LEGYK
Sbjct: 2336 KTIELEALIKRLRSSSKGEKTDYSVKIQELQKQLAMDAEEAEKLQDDRDNFLSLTLEGYK 2395

Query: 903  RCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGST 962
            RCLV+GDKYDVRVVFRLVSLWFSLSSRQNVI  M+ T+ EVQSYKFIPLVYQIASRMGS+
Sbjct: 2396 RCLVLGDKYDVRVVFRLVSLWFSLSSRQNVINMMLSTVQEVQSYKFIPLVYQIASRMGSS 2455

Query: 963  KDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLA 1022
            KD LG H+FQFALVSLVKKM+IDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLA
Sbjct: 2456 KDGLGPHSFQFALVSLVKKMSIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLA 2515

Query: 1023 AENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPV 1082
            AENLL+ELSS HG+II+QMKQMV++YIKLAELET+REDTNKR+ LPREIR LRQLELVPV
Sbjct: 2516 AENLLKELSSCHGSIIQQMKQMVEIYIKLAELETKREDTNKRVMLPREIRSLRQLELVPV 2575

Query: 1083 VTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDD 1142
            VT+T P+D  CQY+EGSFP+FKGL +SVM+MNGINAPKVVEC GSDG KYRQLAKSGNDD
Sbjct: 2576 VTSTFPVDRNCQYHEGSFPHFKGLGDSVMIMNGINAPKVVECLGSDGQKYRQLAKSGNDD 2635

Query: 1143 LRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLI 1202
            LRQDAVMEQFF LVNTFL NHRDTWKRRL VRTYKVVPFTPSAG+LEWV+GT+PLG+YLI
Sbjct: 2636 LRQDAVMEQFFSLVNTFLENHRDTWKRRLRVRTYKVVPFTPSAGVLEWVNGTLPLGEYLI 2695

Query: 1203 GSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAY 1262
            GSTRNGGAHGRYG+ DWSF KCREHM+N KDKR AFQEVC+NFRPV+H FFLERFLQPA 
Sbjct: 2696 GSTRNGGAHGRYGMEDWSFSKCREHMTNEKDKRKAFQEVCKNFRPVMHNFFLERFLQPAD 2755

Query: 1263 WFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPE 1322
            WFEKRLAYTRSVAASSMVGYIVGLGDRH+MNILIDQATAEVVHIDLGVAFEQGLMLKTPE
Sbjct: 2756 WFEKRLAYTRSVAASSMVGYIVGLGDRHSMNILIDQATAEVVHIDLGVAFEQGLMLKTPE 2815

Query: 1323 RVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSP 1382
            RVPFRLTRDIIDGMGVTGVEGVFRRCCE+TLSVMRTNKEALLTIVEVFIHDPLYKWALSP
Sbjct: 2816 RVPFRLTRDIIDGMGVTGVEGVFRRCCEETLSVMRTNKEALLTIVEVFIHDPLYKWALSP 2875

Query: 1383 LKALQRQK 1390
            LKALQRQK
Sbjct: 2876 LKALQRQK 2883




Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297733786|emb|CBI15033.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information
>gi|255540663|ref|XP_002511396.1| ataxia telangiectasia mutated, putative [Ricinus communis] gi|223550511|gb|EEF51998.1| ataxia telangiectasia mutated, putative [Ricinus communis] Back     alignment and taxonomy information
>gi|356507238|ref|XP_003522376.1| PREDICTED: serine/threonine-protein kinase ATM-like [Glycine max] Back     alignment and taxonomy information
>gi|449441017|ref|XP_004138280.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase ATM-like [Cucumis sativus] Back     alignment and taxonomy information
>gi|56748564|sp|Q9M3G7.1|ATM_ARATH RecName: Full=Serine/threonine-protein kinase ATM; AltName: Full=Ataxia telangiectasia mutated homolog; Short=AtATM gi|7960715|emb|CAB92122.1| AtATM [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|7529272|emb|CAB86487.1| ataxia-telangiectasia mutated protein (Atm) [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|240255538|ref|NP_190402.6| serine/threonine-protein kinase [Arabidopsis thaliana] gi|332644858|gb|AEE78379.1| serine/threonine-protein kinase [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|297815998|ref|XP_002875882.1| hypothetical protein ARALYDRAFT_323420 [Arabidopsis lyrata subsp. lyrata] gi|297321720|gb|EFH52141.1| hypothetical protein ARALYDRAFT_323420 [Arabidopsis lyrata subsp. lyrata] Back     alignment and taxonomy information
>gi|222617585|gb|EEE53717.1| hypothetical protein OsJ_00056 [Oryza sativa Japonica Group] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query1408
MGI|MGI:1072023066 Atm "ataxia telangiectasia mut 0.624 0.286 0.371 4.1e-162
ZFIN|ZDB-GENE-040809-12773 atm "ataxia telangiectasia mut 0.628 0.319 0.363 6.5e-160
UNIPROTKB|Q133153056 ATM "Serine-protein kinase ATM 0.622 0.286 0.373 1.9e-158
UNIPROTKB|Q5MPF83061 atm "Ataxia telangiectasia mut 0.622 0.286 0.372 4.7e-157
UNIPROTKB|F1PEL73065 ATM "Uncharacterized protein" 0.623 0.286 0.365 3e-156
RGD|15932653064 Atm "ataxia telangiectasia mut 0.622 0.285 0.373 3e-155
UNIPROTKB|Q6PQD53057 ATM "Serine-protein kinase ATM 0.622 0.286 0.360 3.9e-155
UNIPROTKB|E1BEI63057 ATM "Uncharacterized protein" 0.623 0.287 0.371 3.2e-153
UNIPROTKB|J9JHR53057 ATM "Uncharacterized protein" 0.621 0.286 0.366 5.2e-153
UNIPROTKB|E1C0Q63069 ATM "Uncharacterized protein" 0.779 0.357 0.328 5.1e-145
MGI|MGI:107202 Atm "ataxia telangiectasia mutated homolog (human)" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
 Score = 1420 (504.9 bits), Expect = 4.1e-162, Sum P(3) = 4.1e-162
 Identities = 354/952 (37%), Positives = 534/952 (56%)

Query:   474 GLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANF 533
             G++++LQ +G  H+L +Y KGL   + ++    E  +L+Y+AAWR   W       G   
Sbjct:  2069 GIIQALQNLGLSHILSVYLKGLDYERREWC--AELQELRYQAAWRNMQW-------GLCA 2119

Query:   534 PSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAI 593
              +GQ ++   +HE+L++ L  LR  +   FY  L+++    V  V   S+ S E +YS  
Sbjct:  2120 SAGQEVEGTSYHESLYNALQCLRNREFSTFYESLRYASLFRVKEVEELSKGSLESVYSLY 2179

Query:   594 VKLQILCHLGVAWDIRWKSSGESIN-IYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRT 652
               L  L  +G       ++SGE  +    ++++  +        QL   ++++S      
Sbjct:  2180 PTLSRLQAIG-----ELENSGELFSRSVTDRERSEAYWKWQKHSQLL-KDSDFSFQEPLM 2233

Query:   653 QLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAA-ALHELKFLYT 711
              L   +LE  +       Q    KD   +HL+E  S L + F+ +Q    A+ ++K  Y 
Sbjct:  2234 ALRTVILETLVQKEMERSQGACSKDILTKHLVEF-SVLARTFKNTQLPERAIFKIK-QYN 2291

Query:   712 GPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESN--EEAPD-----VY-- 762
                  C    W   LEEA++  A+ +  +A+++ K + +  +S+  ++  D     +Y  
Sbjct:  2292 SA--ICGISEW--HLEEAQVFWAKKEQSLALSILKQMIKKLDSSFKDKENDAGLKVIYAE 2347

Query:   763 --RLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADAL 820
               R+ G WLAE+   N  +I++ YL+ AV  +       ++    Q +    LA ++D  
Sbjct:  2348 CLRVCGSWLAETCLENPAVIMQTYLEKAVKVAGSYDGNSRELRNGQMKAFLSLARFSDTQ 2407

Query:   821 FKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDR 880
             ++  E  + S+E++    L K    E+  L++  K  T      Y++K+Q   ++L +D 
Sbjct:  2408 YQRIENYMKSSEFENKQTLLKRAKEEV-GLLREHKIQTNR----YTVKVQ---RELELDE 2459

Query:   881 EEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTI 940
                + L +DR  FL  A+E Y  CL+ G+++D+ V FRL SLW   S    V   M    
Sbjct:  2460 CALRALREDRKRFLCKAVENYINCLLSGEEHDLWV-FRLCSLWLENSGVSEVNGMMKKDG 2518

Query:   941 DEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANG 1000
              ++ SYKF+PL+YQ+A+RMG TK   GL  F   L +L+ ++++DHP+HT+F +LALAN 
Sbjct:  2519 MKISSYKFLPLMYQLAARMG-TKMTGGL-GFHEVLNNLISRISLDHPHHTLFIILALANA 2576

Query:  1001 --DRIKDK----QRSR--------NSFVVDMDKKXXXXXXXXXXSSYHGAIIRQMKQMVD 1046
               D    K    +RSR        NS + D D+            S    +++ M+ + D
Sbjct:  2577 NKDEFLSKPETTRRSRITKSTSKENSHL-DEDRTEAATRIIHSIRSKRCKMVKDMEALCD 2635

Query:  1047 VYIKLAELETRR-EDTNKRIQLP--REIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYF 1103
              YI LA ++  +     K I +P  + I  L+ LE V V T  + +D T +Y   +    
Sbjct:  2636 AYIILANMDASQWRAQRKGINIPANQPITKLKNLEDVVVPTMEIKVDPTGEYE--NLVTI 2693

Query:  1104 KGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNH 1163
             K       +  G+N PK+++C GSDG + RQL K G DDLRQDAVM+Q F + NT L+ +
Sbjct:  2694 KSFKTEFRLAGGLNLPKIIDCVGSDGKERRQLVK-GRDDLRQDAVMQQVFQMCNTLLQRN 2752

Query:  1164 RDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLK 1223
              +T KR+L + TYKVVP +  +G+LEW  GTVP+G+YL+ S    GAH RY   D+S  +
Sbjct:  2753 TETRKRKLTICTYKVVPLSQRSGVLEWCTGTVPIGEYLVNS--EDGAHRRYRPNDFSANQ 2810

Query:  1224 CREHMSNVKDKRI-----AFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASS 1278
             C++ M  V+ K        F  +C+NF PV  YF +E+FL PA WFEKRLAYTRSVA SS
Sbjct:  2811 CQKKMMEVQKKSFEEKYDTFMTICQNFEPVFRYFCMEKFLDPAVWFEKRLAYTRSVATSS 2870

Query:  1279 MVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGV 1338
             +VGYI+GLGDRH  NILI++ +AE+VHIDLGVAFEQG +L TPE VPFRL+RDI+DGMG+
Sbjct:  2871 IVGYILGLGDRHVQNILINEQSAELVHIDLGVAFEQGKILPTPETVPFRLSRDIVDGMGI 2930

Query:  1339 TGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQK 1390
             TGVEGVFRRCCEKT+ VMR+++E LLTIVEV ++DPL+ W ++PLKAL  Q+
Sbjct:  2931 TGVEGVFRRCCEKTMEVMRSSQETLLTIVEVLLYDPLFDWTMNPLKALYLQQ 2982


GO:0000077 "DNA damage checkpoint" evidence=IMP
GO:0000166 "nucleotide binding" evidence=IEA
GO:0000723 "telomere maintenance" evidence=IEA
GO:0001666 "response to hypoxia" evidence=ISO
GO:0001756 "somitogenesis" evidence=IGI
GO:0002331 "pre-B cell allelic exclusion" evidence=IMP
GO:0003677 "DNA binding" evidence=IEA
GO:0004672 "protein kinase activity" evidence=IDA;TAS
GO:0004674 "protein serine/threonine kinase activity" evidence=ISO
GO:0004677 "DNA-dependent protein kinase activity" evidence=ISO
GO:0005515 "protein binding" evidence=IPI
GO:0005524 "ATP binding" evidence=IEA
GO:0005634 "nucleus" evidence=ISO;TAS
GO:0005737 "cytoplasm" evidence=ISO
GO:0005819 "spindle" evidence=IDA
GO:0006281 "DNA repair" evidence=IDA;IMP
GO:0006468 "protein phosphorylation" evidence=IDA;TAS
GO:0006974 "response to DNA damage stimulus" evidence=ISO;TAS
GO:0006975 "DNA damage induced protein phosphorylation" evidence=ISO
GO:0007049 "cell cycle" evidence=IEA
GO:0007050 "cell cycle arrest" evidence=ISO
GO:0007094 "mitotic spindle assembly checkpoint" evidence=ISO
GO:0007292 "female gamete generation" evidence=IMP
GO:0007420 "brain development" evidence=IGI
GO:0007507 "heart development" evidence=IGI
GO:0008630 "intrinsic apoptotic signaling pathway in response to DNA damage" evidence=IGI;IMP
GO:0010212 "response to ionizing radiation" evidence=ISO;IGI
GO:0016301 "kinase activity" evidence=IEA
GO:0016303 "1-phosphatidylinositol-3-kinase activity" evidence=ISO
GO:0016310 "phosphorylation" evidence=IEA
GO:0016572 "histone phosphorylation" evidence=ISO
GO:0016740 "transferase activity" evidence=IEA
GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA
GO:0016773 "phosphotransferase activity, alcohol group as acceptor" evidence=IEA
GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO
GO:0030889 "negative regulation of B cell proliferation" evidence=ISO
GO:0031410 "cytoplasmic vesicle" evidence=IEA
GO:0031572 "G2 DNA damage checkpoint" evidence=ISO
GO:0032403 "protein complex binding" evidence=ISO
GO:0035174 "histone serine kinase activity" evidence=ISO
GO:0035404 "histone-serine phosphorylation" evidence=ISO
GO:0036092 "phosphatidylinositol-3-phosphate biosynthetic process" evidence=ISO
GO:0042159 "lipoprotein catabolic process" evidence=IGI
GO:0043065 "positive regulation of apoptotic process" evidence=ISO
GO:0043066 "negative regulation of apoptotic process" evidence=IMP
GO:0043517 "positive regulation of DNA damage response, signal transduction by p53 class mediator" evidence=ISO
GO:0043525 "positive regulation of neuron apoptotic process" evidence=IGI
GO:0046777 "protein autophosphorylation" evidence=ISO
GO:0046983 "protein dimerization activity" evidence=ISO
GO:0047485 "protein N-terminus binding" evidence=ISO
GO:0051402 "neuron apoptotic process" evidence=IGI
GO:0051726 "regulation of cell cycle" evidence=ISO
GO:0071044 "histone mRNA catabolic process" evidence=ISO
GO:0071480 "cellular response to gamma radiation" evidence=ISO
GO:0090399 "replicative senescence" evidence=ISO
ZFIN|ZDB-GENE-040809-1 atm "ataxia telangiectasia mutated" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
UNIPROTKB|Q13315 ATM "Serine-protein kinase ATM" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|Q5MPF8 atm "Ataxia telangiectasia mutated" [Xenopus laevis (taxid:8355)] Back     alignment and assigned GO terms
UNIPROTKB|F1PEL7 ATM "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
RGD|1593265 Atm "ataxia telangiectasia mutated" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|Q6PQD5 ATM "Serine-protein kinase ATM" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|E1BEI6 ATM "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|J9JHR5 ATM "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|E1C0Q6 ATM "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

Prediction LevelEC numberConfidence of Prediction
4th Layer2.7.11.10.737
3rd Layer2.7.110.691

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Fail to connect to STRING server


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1408
cd05171279 cd05171, PIKKc_ATM, Ataxia telangiectasia mutated 1e-173
cd00892237 cd00892, PIKKc_ATR, ATR (Ataxia telangiectasia and 2e-88
cd05164222 cd05164, PIKKc, Phosphoinositide 3-kinase-related 1e-82
cd05169280 cd05169, PIKKc_TOR, TOR (Target of rapamycin), cat 4e-75
smart00146240 smart00146, PI3Kc, Phosphoinositide 3-kinase, cata 2e-67
COG50322105 COG5032, TEL1, Phosphatidylinositol kinase and pro 8e-67
cd00142219 cd00142, PI3Kc_like, Phosphoinositide 3-kinase (PI 3e-60
pfam00454233 pfam00454, PI3_PI4_kinase, Phosphatidylinositol 3- 4e-53
cd05172235 cd05172, PIKKc_DNA-PK, DNA-dependent protein kinas 7e-53
cd05170307 cd05170, PIKKc_SMG1, Suppressor of morphogenetic e 1e-45
pfam02259350 pfam02259, FAT, FAT domain 9e-13
cd00896350 cd00896, PI3Kc_III, Phosphoinositide 3-kinase (PI3 1e-12
cd05167311 cd05167, PI4Kc_III_alpha, Phosphoinositide 4-kinas 1e-12
cd05168293 cd05168, PI4Kc_III_beta, Phosphoinositide 4-kinase 2e-12
cd05170307 cd05170, PIKKc_SMG1, Suppressor of morphogenetic e 3e-12
cd00891352 cd00891, PI3Kc, Phosphoinositide 3-kinase (PI3K), 6e-12
cd00893289 cd00893, PI4Kc_III, Phosphoinositide 4-kinase (PI4 1e-11
cd05163253 cd05163, TRRAP, TRansformation/tRanscription domai 2e-11
cd05173362 cd05173, PI3Kc_IA_beta, Phosphoinositide 3-kinase 2e-09
cd05165366 cd05165, PI3Kc_I, Phosphoinositide 3-kinase (PI3K) 1e-08
cd05174361 cd05174, PI3Kc_IA_delta, Phosphoinositide 3-kinase 2e-06
cd00894365 cd00894, PI3Kc_IB_gamma, Phosphoinositide 3-kinase 9e-06
cd05166353 cd05166, PI3Kc_II, Phosphoinositide 3-kinase (PI3K 6e-05
cd05175366 cd05175, PI3Kc_IA_alpha, Phosphoinositide 3-kinase 5e-04
>gnl|CDD|119431 cd05171, PIKKc_ATM, Ataxia telangiectasia mutated (ATM), catalytic domain; The ATM catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
 Score =  516 bits (1331), Expect = e-173
 Identities = 181/283 (63%), Positives = 221/283 (78%), Gaps = 9/283 (3%)

Query: 1103 FKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRN 1162
                 +      GINAPK++ C GSDG KY+QL K G+DD RQDAVMEQ F LVNT L  
Sbjct: 1    VSKFKDVFTTAGGINAPKIITCVGSDGKKYKQLLKGGDDD-RQDAVMEQVFQLVNTLLER 59

Query: 1163 HRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFL 1222
            +++T KR+L +RTYKVVP +P AGILEWVDGT+PLG+YL+G+T   GAH RY  GDW+  
Sbjct: 60   NKETRKRKLRIRTYKVVPLSPRAGILEWVDGTIPLGEYLVGAT---GAHERYRPGDWTAR 116

Query: 1223 KCREHMSNVK-----DKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAAS 1277
            KCR+ M+ V+     ++   F ++C+NFRPV  YFFLE+FL P  WFE+RLAYTRSVA S
Sbjct: 117  KCRKAMAEVQKESNEERLKVFLKICKNFRPVFRYFFLEKFLDPQDWFERRLAYTRSVATS 176

Query: 1278 SMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMG 1337
            S+VGYI+GLGDRHA NILID+ TAEVVHIDLG+AFEQG +L  PE VPFRLTRDI+DGMG
Sbjct: 177  SIVGYILGLGDRHANNILIDEKTAEVVHIDLGIAFEQGKILPVPETVPFRLTRDIVDGMG 236

Query: 1338 VTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWAL 1380
            +TGVEGVFRRCCEKTL V+R NK+A+LTI+EV ++DPLY W +
Sbjct: 237  ITGVEGVFRRCCEKTLEVLRDNKDAILTILEVLLYDPLYSWTV 279


ATM is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). ATM contains a FAT (FRAP, ATM and TRRAP) domain, a catalytic domain, and a FATC domain at the C-terminus. ATM is critical in the response to DNA double strand breaks (DSBs) caused by radiation. It is activated at the site of a DSB and phosphorylates key substrates that trigger pathways that regulate DNA repair and cell cycle checkpoints at the G1/S, S phase, and G2/M transition. Patients with the human genetic disorder Ataxia telangiectasia (A-T), caused by truncating mutations in ATM, show genome instability, increased cancer risk, immunodeficiency, compromised mobility, and neurodegeneration. A-T displays clinical heterogeneity, which is correlated to the degree of retained ATM activity. Length = 279

>gnl|CDD|119418 cd00892, PIKKc_ATR, ATR (Ataxia telangiectasia and Rad3-related), catalytic domain; The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119424 cd05164, PIKKc, Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119429 cd05169, PIKKc_TOR, TOR (Target of rapamycin), catalytic domain; The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|214538 smart00146, PI3Kc, Phosphoinositide 3-kinase, catalytic domain Back     alignment and domain information
>gnl|CDD|227365 COG5032, TEL1, Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family [Signal transduction mechanisms / Cell division and chromosome partitioning / Chromatin structure and dynamics / DNA replication, recombination, and repair / Intracellular trafficking and secretion] Back     alignment and domain information
>gnl|CDD|119416 cd00142, PI3Kc_like, Phosphoinositide 3-kinase (PI3K)-like family, catalytic domain; The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|189554 pfam00454, PI3_PI4_kinase, Phosphatidylinositol 3- and 4-kinase Back     alignment and domain information
>gnl|CDD|119432 cd05172, PIKKc_DNA-PK, DNA-dependent protein kinase (DNA-PK), catalytic domain; The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119430 cd05170, PIKKc_SMG1, Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|216950 pfam02259, FAT, FAT domain Back     alignment and domain information
>gnl|CDD|119422 cd00896, PI3Kc_III, Phosphoinositide 3-kinase (PI3K), class III, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119427 cd05167, PI4Kc_III_alpha, Phosphoinositide 4-kinase (PI4K), Type III, alpha isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119428 cd05168, PI4Kc_III_beta, Phosphoinositide 4-kinase (PI4K), Type III, beta isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119430 cd05170, PIKKc_SMG1, Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119417 cd00891, PI3Kc, Phosphoinositide 3-kinase (PI3K), catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119419 cd00893, PI4Kc_III, Phosphoinositide 4-kinase (PI4K), Type III, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119423 cd05163, TRRAP, TRansformation/tRanscription domain-Associated Protein (TRRAP), pseudokinase domain; The TRRAP catalytic domain is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119433 cd05173, PI3Kc_IA_beta, Phosphoinositide 3-kinase (PI3K), class IA, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119425 cd05165, PI3Kc_I, Phosphoinositide 3-kinase (PI3K), class I, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119434 cd05174, PI3Kc_IA_delta, Phosphoinositide 3-kinase (PI3K), class IA, delta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119420 cd00894, PI3Kc_IB_gamma, Phosphoinositide 3-kinase (PI3K), class IB, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119426 cd05166, PI3Kc_II, Phosphoinositide 3-kinase (PI3K), class II, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|88554 cd05175, PI3Kc_IA_alpha, Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 1408
KOG08922806 consensus Protein kinase ATM/Tel1, involved in tel 100.0
KOG08902382 consensus Protein kinase of the PI-3 kinase family 100.0
KOG08912341 consensus DNA-dependent protein kinase [Replicatio 100.0
COG50322105 TEL1 Phosphatidylinositol kinase and protein kinas 100.0
cd05171279 PIKKc_ATM Ataxia telangiectasia mutated (ATM), cat 100.0
cd05170307 PIKKc_SMG1 Suppressor of morphogenetic effect on g 100.0
cd05163253 TRRAP TRansformation/tRanscription domain-Associat 100.0
cd05169280 PIKKc_TOR TOR (Target of rapamycin), catalytic dom 100.0
cd05172235 PIKKc_DNA-PK DNA-dependent protein kinase (DNA-PK) 100.0
cd00892237 PIKKc_ATR ATR (Ataxia telangiectasia and Rad3-rela 100.0
KOG08893550 consensus Histone acetyltransferase SAGA, TRRAP/TR 100.0
cd05164222 PIKKc Phosphoinositide 3-kinase-related protein ki 100.0
cd00142219 PI3Kc_like Phosphoinositide 3-kinase (PI3K)-like f 100.0
cd00891352 PI3Kc Phosphoinositide 3-kinase (PI3K), catalytic 100.0
cd05166353 PI3Kc_II Phosphoinositide 3-kinase (PI3K), class I 100.0
cd00896350 PI3Kc_III Phosphoinositide 3-kinase (PI3K), class 100.0
cd05177354 PI3Kc_C2_gamma Phosphoinositide 3-kinase (PI3K), c 100.0
cd05165366 PI3Kc_I Phosphoinositide 3-kinase (PI3K), class I, 100.0
cd05168293 PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), T 100.0
smart00146202 PI3Kc Phosphoinositide 3-kinase, catalytic domain. 100.0
cd05174361 PI3Kc_IA_delta Phosphoinositide 3-kinase (PI3K), c 100.0
cd05173362 PI3Kc_IA_beta Phosphoinositide 3-kinase (PI3K), cl 100.0
cd00893289 PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type I 100.0
cd00894365 PI3Kc_IB_gamma Phosphoinositide 3-kinase (PI3K), c 100.0
cd05176353 PI3Kc_C2_alpha Phosphoinositide 3-kinase (PI3K), c 100.0
PF00454235 PI3_PI4_kinase: Phosphatidylinositol 3- and 4-kina 100.0
cd05167311 PI4Kc_III_alpha Phosphoinositide 4-kinase (PI4K), 100.0
cd00895354 PI3Kc_C2_beta Phosphoinositide 3-kinase (PI3K), cl 100.0
cd05175366 PI3Kc_IA_alpha Phosphoinositide 3-kinase (PI3K), c 100.0
KOG0906843 consensus Phosphatidylinositol 3-kinase VPS34, inv 100.0
KOG0905 1639 consensus Phosphoinositide 3-kinase [Signal transd 100.0
KOG09041076 consensus Phosphatidylinositol 3-kinase catalytic 100.0
PF02259352 FAT: FAT domain; InterPro: IPR003151 The FAT domai 100.0
KOG09021803 consensus Phosphatidylinositol 4-kinase [Signal tr 99.96
KOG0903847 consensus Phosphatidylinositol 4-kinase, involved 99.95
PTZ00303 1374 phosphatidylinositol kinase; Provisional 99.92
KOG0892 2806 consensus Protein kinase ATM/Tel1, involved in tel 98.76
TIGR02917899 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat 96.4
PLN032181060 maturation of RBCL 1; Provisional 93.51
TIGR02917899 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat 93.47
smart00145184 PI3Ka Phosphoinositide 3-kinase family, accessory 92.09
PLN03081697 pentatricopeptide (PPR) repeat-containing protein; 91.96
PRK15174656 Vi polysaccharide export protein VexE; Provisional 91.65
PRK114471157 cellulose synthase subunit BcsC; Provisional 91.26
PLN032181060 maturation of RBCL 1; Provisional 91.06
cd00872171 PI3Ka_I Phosphoinositide 3-kinase (PI3K) class I, 90.63
cd00870166 PI3Ka_III Phosphoinositide 3-kinase (PI3K) class I 89.74
PRK10747398 putative protoheme IX biogenesis protein; Provisio 89.07
cd00864152 PI3Ka Phosphoinositide 3-kinase family, accessory 88.88
PRK15174656 Vi polysaccharide export protein VexE; Provisional 87.93
PLN03081697 pentatricopeptide (PPR) repeat-containing protein; 87.92
PLN03077857 Protein ECB2; Provisional 83.45
PF00613184 PI3Ka: Phosphoinositide 3-kinase family, accessory 83.09
PF13575370 DUF4135: Domain of unknown function (DUF4135) 82.32
TIGR02906313 spore_CotS spore coat protein, CotS family. Member 80.04
>KOG0892 consensus Protein kinase ATM/Tel1, involved in telomere length regulation and DNA repair [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
Probab=100.00  E-value=2.4e-163  Score=1571.62  Aligned_cols=1206  Identities=39%  Similarity=0.575  Sum_probs=960.4

Q ss_pred             cccCCChhHHHHHHHHHHhhcCCCcccHHHHHHHHHhhhCCCCCcEEEEecCCCccccccccCCCCCCCCCccceeccCc
Q 000581            5 VDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDA   84 (1408)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (1408)
                      .+|+.+++++..+|..+++-....+-+.....-+|+.+++..|+|.++|++|+..+++|+-.-..+.  .+.-+.-.+-.
T Consensus      1510 ~~~q~~~e~v~~~~~~~q~~~~~~~~~~~e~~~~~~~~v~~~~~~~L~~~~~~~~~~s~g~~i~~~~--~~~n~~~~~K~ 1587 (2806)
T KOG0892|consen 1510 WFWQKSPEIVDLVHYYPQTDPRLCDTSNYEPSKDFLWKVICQDDCSLLFKLPILLDSSIGIQIRMFF--EGSNIMELTKN 1587 (2806)
T ss_pred             hHHhcCccceechhhcccCChhhhhhcccCchhhhhhchhccccceEEEEcCcccccchhhhhhhcc--ccchhhhhhhh
Confidence            4799999999999999999999999999999999999999999999999999998877754432222  23334444556


Q ss_pred             cchHHHHHHHHHHHHHhhhcCcchhhchHHHHHHHHhcccccchhhhchhHHHHHHHHHhhccCcchhhHhhhhhhhhhh
Q 000581           85 GISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKF  164 (1408)
Q Consensus        85 ~~~~~~~~~il~~l~~~l~~~~~~~~~~a~~~L~~ils~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (1408)
                      ++.++........+..+..+..+.+.....++....+++-.+......++.|.+.+++++                    
T Consensus      1588 ~i~~~dk~~~~~~~~~~~~~~~~~~~~il~~t~~es~s~w~s~~~ls~f~~c~~~~~~~~-------------------- 1647 (2806)
T KOG0892|consen 1588 LIFPLDKITLDSFLKTLVSEEGSFIIDILQQTNNESLSNWLSEFALKLFNMCGRSSTTHS-------------------- 1647 (2806)
T ss_pred             hccchhHHHHHHHHHHHhhccchhHHHHHhhhhccchhhHHHHHHHHHHHHHhccCCchh--------------------
Confidence            788888888888999999999999999999999999999888888777888877777632                    


Q ss_pred             hcCCCCCCCCCccccCCCCHHhhHHHHHHHhhccCCchhhHhcHHHHhhcHhHHHHHhHHHHHHHhcCCCcchhHHHHHH
Q 000581          165 KANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLIS  244 (1408)
Q Consensus       165 ~~~~~~~~~~~~w~~~~~s~~eWlr~l~~~Ll~~~~s~~Lr~~~~l~~~~~~~A~~LfP~~v~~~~~~~d~~~~~~~~Ls  244 (1408)
                                  |.++......|++.+...+|-.+.+..   |..+....--+-+.++|.+..+                
T Consensus      1648 ------------~st~~~~~~t~i~~~i~~~l~~~s~~~---~~~~~~~~~yi~~~~~~sl~~n---------------- 1696 (2806)
T KOG0892|consen 1648 ------------LSTYMANFSTSICQLIICLLLLESDFN---PGNNLKQKDYIFELILSSLLKN---------------- 1696 (2806)
T ss_pred             ------------hccccccccHHHHHHHHHHHHhhcccc---HHHHHHHHHHHHHHHhhccccc----------------
Confidence                        444445568899999988874333322   4444444444444444433200                


Q ss_pred             HHHHhhhhhcchhhHHHHHHHHHHHHHHHHhhHhhhccCCCCCcccccccccCCCCCCCccchhhhhhhhhhcccccccc
Q 000581          245 SQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTS  324 (1408)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~q~~l~~~~~Lr~~~~ae~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (1408)
                                   ......+-+|.+.++|.+   ++..+                                      -+.
T Consensus      1697 -------------~~~~~~m~~ni~~~~~~~---~~~~~--------------------------------------~n~ 1722 (2806)
T KOG0892|consen 1697 -------------SNSIFKMDMNILKYLRRQ---LGCHA--------------------------------------FNP 1722 (2806)
T ss_pred             -------------hhHHHHHHHHHHHHHHHh---hchhh--------------------------------------hcc
Confidence                         011223344555566544   11100                                      023


Q ss_pred             cccccccccCHHHHHHHHHHhchhhhhhhhhHhHHHHhhccccCCCCCCCcCCCcchHHHHHHHHHHhcCCchhhhhhhh
Q 000581          325 WDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQ  404 (1408)
Q Consensus       325 ~~~~~wL~Id~~~lA~aA~~C~aya~ALly~E~~~~~~~~~~~~~~~~~s~~~~~~~~~e~L~~Iy~~IdePD~~yGi~~  404 (1408)
                      |...+|+++++...+-.+.+|.+|-..++|.=+...+          ..++.+.....+++|.++|+.|++||+.||+..
T Consensus      1723 ~~~~~~~~~~~~~~~~~~~~~~~~e~s~~~~t~~~~k----------~k~~e~~~~~lqDil~~~y~~I~~pD~lyG~~~ 1792 (2806)
T KOG0892|consen 1723 FEIYYWLPIVYSVAASTAYDCLLFEYSLLSLTIHSPK----------NKRDELDITLLQDILKKAYESINCPDALYGIKR 1792 (2806)
T ss_pred             hhhhccccHHHHHHHHHHHHHHHHHHHHHHHhhcCcc----------cchhHHHHHHHHHHHHHHHhhCCCcchhcccCC
Confidence            4556789999999888888888888777776542110          111122234456667777999999999999998


Q ss_pred             ccchh-hHHHHHHHhCCHHHHHHHHHHHHhcchhcccCCCCCCCCCCCCCCcCCCCCcchhhhhhccchhHHHHHHHhhc
Q 000581          405 SHKLS-SQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVG  483 (1408)
Q Consensus       405 ~~~l~-~~i~~yE~eg~W~kAL~~Yd~~l~~~~~~~~~~~s~~~~~~~~p~~~~~~~~~e~~~~~~~~~~GlmrcL~~LG  483 (1408)
                      ...++ .++..+||+++|.+||..||..-.                  .|+       ++       ...|.+++|++.|
T Consensus      1793 ~~~~~~~~l~~~~he~~w~~aL~~~d~~~~------------------~~s-------s~-------~~~~~~~sLq~~g 1840 (2806)
T KOG0892|consen 1793 PTSLKNLILITAEHEKNWPRALSYYDLADM------------------YPS-------SE-------DEAGFINSLQNAG 1840 (2806)
T ss_pred             cccccccccchhhhhhhHHHHHHhhcchhh------------------ccc-------hH-------hHhHHHHHHHHhc
Confidence            77777 689999999999999999998643                  233       12       2489999999999


Q ss_pred             hhhHHHHhhhccccccCCCCCCcchHHHHHHHHHhCCCCCCCccccCCCCCCCcCcccchhhhhHHHHHHHHhcCChHHH
Q 000581          484 CMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEF  563 (1408)
Q Consensus       484 ~~~~L~~y~~gl~~~~~~~~~~~~~~~~~~eaAWrlg~WD~~~~~~~~~~~~~~~~~~~~f~~~L~~aL~al~~~d~~~~  563 (1408)
                      +.|++..|++|++...  ..++++..+..|++|||+|+||...+++-+    .....+..||..+|.+++|+++++++++
T Consensus      1841 ~~~I~~~y~~Gl~~~~--~~~~~~~~e~~Ye~awr~g~Wd~~t~~~~~----~~~~~~~~y~e~~f~~l~al~ere~e~~ 1914 (2806)
T KOG0892|consen 1841 FFHILEFYIDGLKSND--KIDEPSNEELVYEAAWRLGKWDILTLSLVD----QNKTKGDYYHESLFEALRALHEREIEGS 1914 (2806)
T ss_pred             chhHHHHHhcChhhhh--hhhhhhhhhhhHHHHHhcCCcccCCcchhh----hhhhhchhHHHHHHHHHHHHHHHHHhhh
Confidence            9999999999999875  467788889999999999999986543211    1445677899999999999999999999


Q ss_pred             HHHHHHHHHHHHHHhhhhhhhhHHHHHHHHHHHhHHhHHHHHHHhhhhcc-CCccccccccccccCCCCCcchhhhhHHH
Q 000581          564 YRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSS-GESINIYPEKQKIVSEPVIPTVGQLSWLN  642 (1408)
Q Consensus       564 ~~~i~~aR~~l~~~Ls~~s~ES~~~~y~~lvrLq~L~ELeei~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  642 (1408)
                      ..+++.+|...+..++..+.|+....|+.+.+||.+.+||.+.++.+... ++.......+.....++..+..+..+++.
T Consensus      1915 yl~le~a~~~~v~~i~~~see~~~~~y~~l~~L~~l~~l~~i~~l~~~~~~~~~~~~~~~k~~t~~q~~~~~~~~~~~~~ 1994 (2806)
T KOG0892|consen 1915 YLHLEDARNKKVLLINPNSEESSLSFYATLYDLQFLVTLEPIRCLQSTADKHQSNTDILQKWKTNLQLSSQLMECLSLLI 1994 (2806)
T ss_pred             HHHHHHHHHHHHHHhcccchHHHHHHHHHHHHHHHHhhhhhhHhhhhhhcchhhhhHHHHHHHHHHhhccchHHHHHHHH
Confidence            99999999999999999999999999999999999999999999876322 10000000011001111111223333444


Q ss_pred             HHHHHHHHhhhcchhhhhhhHHHHHHHHHhhccchHHHHHHHHHHHHHHhcCChhHHHHHHHHHHhhcCCCCCCCchhhh
Q 000581          643 TEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYW  722 (1408)
Q Consensus       643 ~~W~~rl~~~q~~~~~~epil~~R~~vl~il~~~~~~~~~wl~~a~laRkag~~~~A~~aL~~l~~l~~~~~~q~~~~~~  722 (1408)
                      ..|+..+...+.+...-++.++.+..++...+++...+..-++.+.+.++-.+  .+.+...+.+.++            
T Consensus      1995 ~d~n~l~s~~~l~~~l~~~~~~~~~~~l~~~g~e~~~la~~~~~~~~~~~~~r--~~~~i~~~~~~~~------------ 2060 (2806)
T KOG0892|consen 1995 EDRNVLLSLLQLHKQLSESQLADLASLLKYYGLELCKLAESFLIADLLQNIAR--AFPVIMLSIKLLC------------ 2060 (2806)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHhchhhHHhHHH--hhHHHHHHHHHHh------------
Confidence            44444444444444444444444444444444443333333333333333222  2222222222222            


Q ss_pred             hHHHHHHHHHHHcCChH-------------HHHHHHHHHH-hhccCCCchhHHHHHHhHHHHhhhcCChHHHHHHhhccc
Q 000581          723 LGRLEEAKLLRAQGQHE-------------MAINLAKYIS-ENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPA  788 (1408)
Q Consensus       723 ~a~lE~Ak~LW~~Ge~~-------------~Ai~~Lk~i~-~~~~~~~~~a~l~~llG~wlaet~~e~~~~I~~~Y~~~a  788 (1408)
                        .++.|+..|+++...             +++.++.... ++...+....++++.+|+|++|++++++..|+++|+++|
T Consensus      2061 --~~s~aq~~~k~~~~~~~e~iL~~~~~kne~~~~~s~~~~~~~~lk~~~~~~~a~~g~Wlaetk~ens~~i~e~yl~~a 2138 (2806)
T KOG0892|consen 2061 --KFSLAQENLKHDIDKLSEAILWQRDEKNEAIISLSESLAKNNSLKEFPSDIYAVLGKWLAETKSENSALISEKYLEKA 2138 (2806)
T ss_pred             --hhhhhhhhccchhhhhHHHHHHHHHhhhhHHHHHHhhhhhcchhhhhHHHHHHHHHHHHHHhhccchhhhHHHHHHHH
Confidence              233444444443322             2222222222 222233456889999999999999999999999999999


Q ss_pred             cccccccccch-hHHHHHhhhhhhHHHHHHHHHHHhHHHHhchHHHHHHHHHhhhhHHHHHHHHHHHhhcccCccchhhH
Q 000581          789 VSFSEDQRTTD-KKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSI  867 (1408)
Q Consensus       789 ~~~~~~~~~~~-~~~~~~~~~~~~~lA~f~d~~~~~~~~~~~~~e~~~~~~~~~~~~~el~~l~~~~~~~~~~~~~~y~~  867 (1408)
                      +..++.+.... ++.......+++++|+|.|.+|+.+++|+++.+|+.+++++++..++++.+.++-...    +   +.
T Consensus      2139 ~~~ae~~d~e~~~~~~~~~s~a~~~~akysd~~~~~~~~~~~sse~et~~~l~k~~~~~~~~~~er~~q~----~---~~ 2211 (2806)
T KOG0892|consen 2139 VSLAEHYDNESCKALIYCQSFAQFCLAKYSDPDYQEDEERRSSSEFETLKDLQKLERSTVEASNEREEQM----R---KN 2211 (2806)
T ss_pred             HHHhhhcchhHHHHHHhHHHHHHHHHHhccCchhhhHHHHHhHHHHhhHHHHHHHHHhhhhhhHHHHHHH----H---HH
Confidence            98887663222 2334455689999999999999999999999999999999999988888654443221    1   12


Q ss_pred             HHHHHHHHHhhcHHHHHHhHHhHHHHHHHHHHHHHHHhccCCCccHHHHHHHHHHhhccCChHHHHHHHHHhhcccCccc
Q 000581          868 KIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYK  947 (1408)
Q Consensus       868 ~~~~~~~~~~lD~~e~~~l~~~~~~fl~~Ai~~Yl~sL~~~~~~~~~~~~RllsLWl~~~~~~~v~~~~~~~l~~vPs~k  947 (1408)
                      +..+.++++.+|++++.++..+|.+||..|++||++|+..|++|+...++|+|+|||++++.+++++.|.+.+.+||+||
T Consensus      2212 ~~~~~~rq~~lDe~~l~~l~~~r~~fL~~Alt~Yl~cl~~~~~~D~~~i~R~cslWfsns~~~evn~~mk~~i~~ipsyK 2291 (2806)
T KOG0892|consen 2212 HHVRVQRQLILDEEELLALSEDRSKFLTLALTNYLNCLSESDEYDVDLIFRCCSLWFSNSHLKEVNNSLKHEIQTVPSYK 2291 (2806)
T ss_pred             HHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHhHHHHHhhcccccHHHHHHHhhhhccccchHHHHHHHHHHhccCCcch
Confidence            44567899999999999999999999999999999999999999998999999999999999999999999999999999


Q ss_pred             hhhhhHHHhhhcCCCccccccccHHHHHHHHHHHHHHhCChhHHHHHHHhhcCcc-chhhcccccchhhhhhHHHHHHHH
Q 000581          948 FIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDR-IKDKQRSRNSFVVDMDKKLAAENL 1026 (1408)
Q Consensus       948 fl~~lpQLisRL~~~~~~~~~~~f~~~L~~Ll~ri~~~hP~~~ly~l~~~~~s~~-~~~~~~~~~~~~v~~~~~~~a~~i 1026 (1408)
                      |+||++||+|||+.    .++..||+.|..|+.+++++||||++|+|+++.+.++ .++..+++.+  ++.+|..+|+.+
T Consensus      2292 Fip~~yQlAaRl~~----~~~~~fq~~L~~Li~r~~~dhPyhtly~L~~L~~~~rd~e~~n~sr~s--l~~~rki~a~l~ 2365 (2806)
T KOG0892|consen 2292 FIPLVYQLAARLGN----SENNSFQKSLTSLIYRVGRDHPYHTLYQLLSLVNAVRDNEDENRSRGS--IDRDRKIAAELD 2365 (2806)
T ss_pred             hHHHHHHHHHHhcc----ccCchHHHHHHHHHHHHhccCchHHHHHHHHHHhcCcChhhhhhcccc--cchhHHHHHHHh
Confidence            99999999999994    2467899999999999999999999999999998877 4556667765  788999999999


Q ss_pred             HHHHHhhHHHHHHHHHHHHHHHHHHHhhhccccccccc-ccchhh--hhhccccccccccccccCCCCCCcccCCCcccc
Q 000581         1027 LEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKR-IQLPRE--IRCLRQLELVPVVTATVPIDCTCQYNEGSFPYF 1103 (1408)
Q Consensus      1027 l~~l~~~~~~~~~~~~~l~~~~~~la~~~~~~~~~~~~-~~l~~~--l~~l~~l~~~p~~t~~lp~~~~~~y~~~~~~~i 1103 (1408)
                      +.......+.++++++.+|++|+.||+.++.+.++..+ +.+|..  +.+..+++.+|+||+++++++++.|  +++|+|
T Consensus      2366 ~~~v~~~~~~~v~~v~~lc~~yI~lAnl~~~q~~t~~k~v~~p~~~~~~K~~nl~~v~~pT~ev~v~~s~~~--~~~p~i 2443 (2806)
T KOG0892|consen 2366 LCDVNQGAGNMVRQLECLCEAYISLANLKTSQNDTTSKLVRLPGYQWFLKQLNLEGVPPPTMNVKVNDSGDY--GNIPTV 2443 (2806)
T ss_pred             hhHhhccchhHHHHHHHHHHHHHHHhcCcccccchhhhhhcCccccHHHhhhhccCCCCCCCCccccCCccc--CCCceE
Confidence            99988899999999999999999999987776666655 556554  4455677888999999999887755  558999


Q ss_pred             ccccceEEEecCCCcceEEEEEeCCCcEEeeeeecCccchhhhHHHHHHHHHHHHHHhcCcccccccceeecceEEEcCC
Q 000581         1104 KGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTP 1183 (1408)
Q Consensus      1104 ~~f~~~v~v~~s~~~Pk~i~~~gsdG~~y~~L~K~g~dDlRqD~r~~Qlf~liN~lL~~~~et~~r~L~i~tY~ViPLs~ 1183 (1408)
                      .+|.++|.+++|++.||+|+|.||||++|++|+|+|+||||||++|+|+|+++|++|.++++|++|+|.|||||||||+|
T Consensus      2444 ~s~~~~v~~~~GinaPkiI~c~gSDG~~~kqLVK~gnDDLRQDAVMeQvF~~vN~lL~~~~et~krkL~irTYKVvPls~ 2523 (2806)
T KOG0892|consen 2444 VSFDDTVTFAGGINAPKVITCVGSDGKTYKQLVKGGNDDLRQDAVMEQVFGQVNTFLQNDRETRKRKLSIRTYKVIPLSP 2523 (2806)
T ss_pred             EecccceeeecCccCCeEEEEEccCchhHHHHHhcccchHHHHHHHHHHHHHHHHHhhccHHHHhcccceeEEeeeecCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcceEEEcCCCCchHHHhhhcccCCCCCCCCCCCchhhHHHHhhhcchH-----hHHHHHHHHHhhhhhhHHHHHHHHcC
Q 000581         1184 SAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVK-----DKRIAFQEVCENFRPVLHYFFLERFL 1258 (1408)
Q Consensus      1184 ~~GlIE~v~~t~tl~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~k~~~f~~i~~~~~pvl~~~f~~~f~ 1258 (1408)
                      .+|+||||.||+||++||....  +|+|+||+|+||++.+||++|++.+     +|+++|.+||.+|.||||+||+|.||
T Consensus      2524 ~sGvlEwv~~tiplgeyLv~~~--~gah~ry~p~d~s~~~crk~m~~~q~k~~E~r~k~y~~vc~n~~PvfryFflEkF~ 2601 (2806)
T KOG0892|consen 2524 KAGVLEWVTNTIPLGEYLVVES--GGAHKRYRPNDWSLSKCRKLMSEVQKKSLETRLKAYDKVCRNIRPVFRYFFLEKFP 2601 (2806)
T ss_pred             ccceeecccCCeehhhhhcccC--CccccccCCCCCChHHHHHHHHHHhcccHHHHHHHHHHHHhhchHHHHHHHHHhcC
Confidence            9999999999999999998644  8999999999999999999998766     89999999999999999999999999


Q ss_pred             CchHHHHHHHHHHHhhhccchhhheeccCCCCCCeeEEecCCCeEEEeechhhhcccCCCCCCCCCCcccccchhhcccc
Q 000581         1259 QPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGV 1338 (1408)
Q Consensus      1259 ~~~~w~~~R~~ft~S~A~~S~vgyiLgLGDRH~~NILld~~tG~vvHIDfg~~f~~g~~l~~pE~VPFRLTrniv~~mG~ 1338 (1408)
                      +|.+||++|++||||+|+.|||||||||||||.+|||||..||||||||||++||||+.+|+||+||||||||||||||+
T Consensus      2602 dP~~WFekrlaYTrsvA~sS~VGyILGLGDRH~qNILid~~taEviHIDlGiAFEQGkilptPE~VPFRLTRDiVdgmGI 2681 (2806)
T KOG0892|consen 2602 DPADWFEKRLAYTRSVAASSMVGYILGLGDRHGQNILIDQQTAEVIHIDLGIAFEQGKILPTPETVPFRLTRDIVDGMGI 2681 (2806)
T ss_pred             CHHHHHHHHHHHHHhHHHHHHHHHHhcccchhhhheeecccccceEEEeeeeehhcCCcCCCCCcccceeehhhccccCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccchhHHHHHHHHHHHhcCchHHHHHHHHhccCCccccccChHHHHHHHHHHhhcCCC
Q 000581         1339 TGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKAWKAQKMN 1398 (1408)
Q Consensus      1339 ~g~eG~Fr~~c~~t~~~LR~~~~~l~~iLe~f~~Dpl~~W~~~~~~~~~~~~~~~~~~~~ 1398 (1408)
                      |||||+||||||.||.+||++++++++|||+|+||||++|.++|+|++++|++++++++|
T Consensus      2682 tGveGvFrRccE~t~~vlR~~~~~lltileVl~yDPLf~W~msplK~~~~q~~e~~e~~n 2741 (2806)
T KOG0892|consen 2682 TGVEGVFRRCCEFTLEVLRREKESLLTILEVLLYDPLFSWLMSPLKALKKQKEEDEENFN 2741 (2806)
T ss_pred             cCchHHHHHHHHHHHHHHHhhhHHHHHHHHHHHhcchHHHhhcHHHHHHHHHhhcchhcc
Confidence            999999999999999999999999999999999999999999999999999998889999



>KOG0890 consensus Protein kinase of the PI-3 kinase family involved in mitotic growth, DNA repair and meiotic recombination [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>KOG0891 consensus DNA-dependent protein kinase [Replication, recombination and repair] Back     alignment and domain information
>COG5032 TEL1 Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family [Signal transduction mechanisms / Cell division and chromosome partitioning / Chromatin structure and dynamics / DNA replication, recombination, and repair / Intracellular trafficking and secretion] Back     alignment and domain information
>cd05171 PIKKc_ATM Ataxia telangiectasia mutated (ATM), catalytic domain; The ATM catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05170 PIKKc_SMG1 Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05163 TRRAP TRansformation/tRanscription domain-Associated Protein (TRRAP), pseudokinase domain; The TRRAP catalytic domain is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05169 PIKKc_TOR TOR (Target of rapamycin), catalytic domain; The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05172 PIKKc_DNA-PK DNA-dependent protein kinase (DNA-PK), catalytic domain; The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00892 PIKKc_ATR ATR (Ataxia telangiectasia and Rad3-related), catalytic domain; The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>KOG0889 consensus Histone acetyltransferase SAGA, TRRAP/TRA1 component, PI-3 kinase superfamily [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>cd05164 PIKKc Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00142 PI3Kc_like Phosphoinositide 3-kinase (PI3K)-like family, catalytic domain; The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00891 PI3Kc Phosphoinositide 3-kinase (PI3K), catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05166 PI3Kc_II Phosphoinositide 3-kinase (PI3K), class II, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00896 PI3Kc_III Phosphoinositide 3-kinase (PI3K), class III, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05177 PI3Kc_C2_gamma Phosphoinositide 3-kinase (PI3K), class II, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05165 PI3Kc_I Phosphoinositide 3-kinase (PI3K), class I, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05168 PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), Type III, beta isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>smart00146 PI3Kc Phosphoinositide 3-kinase, catalytic domain Back     alignment and domain information
>cd05174 PI3Kc_IA_delta Phosphoinositide 3-kinase (PI3K), class IA, delta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05173 PI3Kc_IA_beta Phosphoinositide 3-kinase (PI3K), class IA, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00893 PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type III, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00894 PI3Kc_IB_gamma Phosphoinositide 3-kinase (PI3K), class IB, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05176 PI3Kc_C2_alpha Phosphoinositide 3-kinase (PI3K), class II, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>PF00454 PI3_PI4_kinase: Phosphatidylinositol 3- and 4-kinase; InterPro: IPR000403 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases Back     alignment and domain information
>cd05167 PI4Kc_III_alpha Phosphoinositide 4-kinase (PI4K), Type III, alpha isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00895 PI3Kc_C2_beta Phosphoinositide 3-kinase (PI3K), class II, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05175 PI3Kc_IA_alpha Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>KOG0906 consensus Phosphatidylinositol 3-kinase VPS34, involved in signal transduction [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] Back     alignment and domain information
>KOG0905 consensus Phosphoinositide 3-kinase [Signal transduction mechanisms] Back     alignment and domain information
>KOG0904 consensus Phosphatidylinositol 3-kinase catalytic subunit (p110) [Signal transduction mechanisms] Back     alignment and domain information
>PF02259 FAT: FAT domain; InterPro: IPR003151 The FAT domain is a domain present in the PIK-related kinases Back     alignment and domain information
>KOG0902 consensus Phosphatidylinositol 4-kinase [Signal transduction mechanisms] Back     alignment and domain information
>KOG0903 consensus Phosphatidylinositol 4-kinase, involved in intracellular trafficking and secretion [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] Back     alignment and domain information
>PTZ00303 phosphatidylinositol kinase; Provisional Back     alignment and domain information
>KOG0892 consensus Protein kinase ATM/Tel1, involved in telomere length regulation and DNA repair [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>TIGR02917 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat lipoprotein Back     alignment and domain information
>PLN03218 maturation of RBCL 1; Provisional Back     alignment and domain information
>TIGR02917 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat lipoprotein Back     alignment and domain information
>smart00145 PI3Ka Phosphoinositide 3-kinase family, accessory domain (PIK domain) Back     alignment and domain information
>PLN03081 pentatricopeptide (PPR) repeat-containing protein; Provisional Back     alignment and domain information
>PRK15174 Vi polysaccharide export protein VexE; Provisional Back     alignment and domain information
>PRK11447 cellulose synthase subunit BcsC; Provisional Back     alignment and domain information
>PLN03218 maturation of RBCL 1; Provisional Back     alignment and domain information
>cd00872 PI3Ka_I Phosphoinositide 3-kinase (PI3K) class I, accessory domain ; PIK domain is conserved in all PI3 and PI4-kinases Back     alignment and domain information
>cd00870 PI3Ka_III Phosphoinositide 3-kinase (PI3K) class III, accessory domain (PIK domain); PIK domain is conserved in all PI3 and PI4-kinases Back     alignment and domain information
>PRK10747 putative protoheme IX biogenesis protein; Provisional Back     alignment and domain information
>cd00864 PI3Ka Phosphoinositide 3-kinase family, accessory domain (PIK domain); PIK domain is conserved in PI3 and PI4-kinases Back     alignment and domain information
>PRK15174 Vi polysaccharide export protein VexE; Provisional Back     alignment and domain information
>PLN03081 pentatricopeptide (PPR) repeat-containing protein; Provisional Back     alignment and domain information
>PLN03077 Protein ECB2; Provisional Back     alignment and domain information
>PF00613 PI3Ka: Phosphoinositide 3-kinase family, accessory domain (PIK domain); InterPro: IPR001263 Phosphatidylinositol 3-kinase (PI3-kinase) (2 Back     alignment and domain information
>PF13575 DUF4135: Domain of unknown function (DUF4135) Back     alignment and domain information
>TIGR02906 spore_CotS spore coat protein, CotS family Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1408
2y3a_A1092 Crystal Structure Of P110beta In Complex With Icsh2 2e-09
3ls8_A614 Crystal Structure Of Human Pik3c3 In Complex With 3 2e-08
3ihy_A600 Human Pik3c3 Crystal Structure Length = 600 2e-08
2x6f_A696 The Crystal Structure Of The Drosophila Class Iii P 7e-08
1e8x_A961 Structural Insights Into Phoshoinositide 3-Kinase E 6e-07
1e7u_A961 Structure Determinants Of Phosphoinositide 3-Kinase 6e-07
1e8y_A966 Structure Determinants Of Phosphoinositide 3-Kinase 5e-06
3qaq_A960 Crystal Structure Of Pi3k-Gamma In Complex With Tri 5e-06
4dk5_A959 Crystal Structure Of Human Pi3k-Gamma In Complex Wi 5e-06
3ene_A959 Complex Of Pi3k Gamma With An Inhibitor Length = 95 5e-06
3l54_A966 Structure Of Pi3k Gamma With Inhibitor Length = 966 5e-06
1he8_A965 Ras G12v-Pi 3-Kinase Gamma Complex Length = 965 5e-06
3apc_A966 Crystal Structure Of Human Pi3k-Gamma In Complex Wi 5e-06
3dbs_A960 Structure Of Pi3k Gamma In Complex With Gdc0941 Len 5e-06
3cst_A966 Crystal Structure Of Pi3k P110gamma Catalytical Dom 5e-06
3nzs_A954 Structure-Based Optimization Of Pyrazolo -Pyrimidin 6e-06
4anv_A980 Complexes Of Pi3kgamma With Isoform Selective Inhib 6e-06
4anu_A980 Complexes Of Pi3kgamma With Isoform Selective Inhib 6e-06
4anx_A980 Complexes Of Pi3kgamma With Isoform Selective Inhib 1e-05
4ajw_A934 Discovery And Optimization Of New Benzimidazole- An 2e-05
2wxf_A940 The Crystal Structure Of The Murine Class Ia Pi 3-K 2e-05
3zim_A940 Discovery Of A Potent And Isoform-selective Targete 9e-05
3hiz_A1096 Crystal Structure Of P110alpha H1047r Mutant In Com 1e-04
3hhm_A1091 Crystal Structure Of P110alpha H1047r Mutant In Com 1e-04
4a55_A1096 Crystal Structure Of P110alpha In Complex With Ish2 1e-04
2rd0_A1096 Structure Of A Human P110alpha/p85alpha Complex Len 1e-04
>pdb|2Y3A|A Chain A, Crystal Structure Of P110beta In Complex With Icsh2 Of P85beta And The Drug Gdc-0941 Length = 1092 Back     alignment and structure

Iteration: 1

Score = 62.4 bits (150), Expect = 2e-09, Method: Compositional matrix adjust. Identities = 37/110 (33%), Positives = 59/110 (53%), Gaps = 10/110 (9%) Query: 1270 YTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLG---VAFEQGLMLKTPERVPF 1326 +T S A + Y++G+GDRH+ NI++ + T ++ HID G F+ +K ERVPF Sbjct: 923 FTLSCAGYCVASYVLGIGDRHSDNIMV-KKTGQLFHIDFGHILGNFKSKFGIKR-ERVPF 980 Query: 1327 RLTRDIIDGM-----GVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFI 1371 LT D I + G T G FR+CCE ++R + +T+ + + Sbjct: 981 ILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALML 1030
>pdb|3LS8|A Chain A, Crystal Structure Of Human Pik3c3 In Complex With 3-[4-(4- Morpholinyl)thieno[3,2-D]pyrimidin-2-Yl]-Phenol Length = 614 Back     alignment and structure
>pdb|3IHY|A Chain A, Human Pik3c3 Crystal Structure Length = 600 Back     alignment and structure
>pdb|2X6F|A Chain A, The Crystal Structure Of The Drosophila Class Iii Pi3-Kinase Vps34 In Complex With 3-Methyladenine Length = 696 Back     alignment and structure
>pdb|1E8X|A Chain A, Structural Insights Into Phoshoinositide 3-Kinase Enzymatic Mechanism And Signalling Length = 961 Back     alignment and structure
>pdb|1E8Y|A Chain A, Structure Determinants Of Phosphoinositide 3-Kinase Inhibition By Wortmannin, Ly294002, Quercetin, Myricetin And Staurosporine Length = 966 Back     alignment and structure
>pdb|3QAQ|A Chain A, Crystal Structure Of Pi3k-Gamma In Complex With Triazine-Benzimidazole 1 Length = 960 Back     alignment and structure
>pdb|4DK5|A Chain A, Crystal Structure Of Human Pi3k-Gamma In Complex With A Pyridyl- Triazine Inhibitor Length = 959 Back     alignment and structure
>pdb|3ENE|A Chain A, Complex Of Pi3k Gamma With An Inhibitor Length = 959 Back     alignment and structure
>pdb|3L54|A Chain A, Structure Of Pi3k Gamma With Inhibitor Length = 966 Back     alignment and structure
>pdb|1HE8|A Chain A, Ras G12v-Pi 3-Kinase Gamma Complex Length = 965 Back     alignment and structure
>pdb|3APC|A Chain A, Crystal Structure Of Human Pi3k-Gamma In Complex With Ch5132799 Length = 966 Back     alignment and structure
>pdb|3DBS|A Chain A, Structure Of Pi3k Gamma In Complex With Gdc0941 Length = 960 Back     alignment and structure
>pdb|3CST|A Chain A, Crystal Structure Of Pi3k P110gamma Catalytical Domain In Complex With Organoruthenium Inhibitor E5e2 Length = 966 Back     alignment and structure
>pdb|3NZS|A Chain A, Structure-Based Optimization Of Pyrazolo -Pyrimidine And -Pyridine Inhibitors Of Pi3-Kinase Length = 954 Back     alignment and structure
>pdb|4ANV|A Chain A, Complexes Of Pi3kgamma With Isoform Selective Inhibitors Length = 980 Back     alignment and structure
>pdb|4ANU|A Chain A, Complexes Of Pi3kgamma With Isoform Selective Inhibitors. Length = 980 Back     alignment and structure
>pdb|4ANX|A Chain A, Complexes Of Pi3kgamma With Isoform Selective Inhibitors Length = 980 Back     alignment and structure
>pdb|4AJW|A Chain A, Discovery And Optimization Of New Benzimidazole- And Benzoxazole- Pyrimidone Selective Pi3kbeta Inhibitors For The Treatment Of Phosphatase And Tensin Homologue (Pten)-Deficient Cancers Length = 934 Back     alignment and structure
>pdb|2WXF|A Chain A, The Crystal Structure Of The Murine Class Ia Pi 3-Kinase P110delta In Complex With Pik-39. Length = 940 Back     alignment and structure
>pdb|3ZIM|A Chain A, Discovery Of A Potent And Isoform-selective Targeted Covalent Inhibitor Of The Lipid Kinase Pi3kalpha Length = 940 Back     alignment and structure
>pdb|3HIZ|A Chain A, Crystal Structure Of P110alpha H1047r Mutant In Complex With Nish2 Of P85alpha Length = 1096 Back     alignment and structure
>pdb|3HHM|A Chain A, Crystal Structure Of P110alpha H1047r Mutant In Complex With Nish2 Of P85alpha And The Drug Wortmannin Length = 1091 Back     alignment and structure
>pdb|4A55|A Chain A, Crystal Structure Of P110alpha In Complex With Ish2 Of P85alpha And The Inhibitor Pik-108 Length = 1096 Back     alignment and structure
>pdb|2RD0|A Chain A, Structure Of A Human P110alpha/p85alpha Complex Length = 1096 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1408
3ls8_A614 Phosphatidylinositol 3-kinase catalytic subunit ty 5e-30
1e7u_A961 Phosphatidylinositol 3-kinase catalytic subunit; p 1e-26
2x6h_A696 GH13170P, VPS34, phosphotidylinositol 3 kinase 59F 4e-22
2y3a_A1092 Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca 4e-22
3hhm_A1091 Phosphatidylinositol-4,5-bisphosphate 3-kinase cat 4e-21
2wxf_A940 Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca 3e-20
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 4e-18
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-11
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 6e-10
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 7e-10
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 7e-10
3lvg_D190 LCB, clathrin light chain B; SELF assembly, coated 2e-04
>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A Length = 614 Back     alignment and structure
 Score =  126 bits (318), Expect = 5e-30
 Identities = 85/525 (16%), Positives = 179/525 (34%), Gaps = 66/525 (12%)

Query: 874  KQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVI 933
            ++ A+ R    +  D+      L L    +     D  +     +  S   S+S   +  
Sbjct: 112  RRYAVARLR--QADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDS-QSSVSENVSNS 168

Query: 934  KNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPY--HTI 991
                  ID  Q                 TK+     N +  L + +   A  +    + +
Sbjct: 169  GINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYL 228

Query: 992  FQLLA--LANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYI 1049
            +  +     + D  +   ++   ++  M +   A    ++      +++   +  VD  +
Sbjct: 229  YWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLV 288

Query: 1050 KLA-ELETRREDTNKRIQLPREIRC-LRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLA 1107
             L   ++    +  K+ +  + +     ++ L  V    +P++               + 
Sbjct: 289  HLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLE-------PQVKIRGIIP 341

Query: 1108 ESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTW 1167
            E+  +      P  +     DG KY  + K G+D LRQD ++ Q   L++  LR      
Sbjct: 342  ETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDD-LRQDQLILQIISLMDKLLRKE---- 396

Query: 1168 KRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREH 1227
               L +  YKV+  +   G ++++         +       G+   +             
Sbjct: 397  NLDLKLTPYKVLATSTKHGFMQFIQSVP-----VAEVLDTEGSIQNF------------- 438

Query: 1228 MSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLG 1287
                                    +            E    Y +S A   ++ YI+G+G
Sbjct: 439  ---------------------FRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVG 477

Query: 1288 DRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEG--VF 1345
            DRH  N+L+ + T ++ HID G    +      P   P +L +++++GMG T  E    F
Sbjct: 478  DRHLDNLLLTK-TGKLFHIDFGYILGRD---PKPLPPPMKLNKEMVEGMGGTQSEQYQEF 533

Query: 1346 RRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQK 1390
            R+ C      +R     +L +  + +   +   AL P K +++ +
Sbjct: 534  RKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQ 578


>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* Length = 696 Back     alignment and structure
>2y3a_A Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca subunit beta isoform; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} Length = 1092 Back     alignment and structure
>3hhm_A Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_A 2rd0_A 4a55_A* 2enq_A Length = 1091 Back     alignment and structure
>2wxf_A Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca subunit delta isoform; transferase, phosphoprotein, isoform-specific inhibitors; HET: 039; 1.90A {Mus musculus} PDB: 2wxg_A* 2wxh_A* 2wxi_A* 2wxj_A* 2wxk_A* 2wxl_A* 2wxm_A* 2wxn_A* 2wxo_A* 2wxp_A* 2wxq_A* 2wxr_A 2x38_A* Length = 940 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 Back     alignment and structure

Structure Templates Detected by HHsearch ?

No hit with probability above 80.00


Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 1408
d1e7ua4369 d.144.1.4 (A:726-1094) Phoshoinositide 3-kinase (P 4e-55

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query1408
d1e7ua4369 Phoshoinositide 3-kinase (PI3K), catalytic domain 100.0
d1e7ua1201 Phoshoinositide 3-kinase (PI3K) helical domain {Pi 88.18